From: Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study
Predictor | Maternal outcome | Fetal and perinatal outcomes | ||||||
---|---|---|---|---|---|---|---|---|
Preeclampsia | p | Macrosomia | p | Admission to NICU | P | Deatha | p | |
Total sample = 444 | Total sample = 436 | Total sample = 424 | Total sample = 567 | |||||
Center (HNSC) | 1.335 (0.993–1.795) | 0.056 | 1.011 (0.686–1.489) | 0.958 | 0.837 (0.660–1.062) | 0.144 | 1.075 (0.456–2.534) | 0.869 |
Age | 1.009 (0.985–1.033) | 0.482 | 0.989 (0.957–1.023) | 0.534 | 0.980 (0.960–0.999) | 0.049 | ||
Diabetes duration | 1.005 (0.971–1.040) | 0.775 | 0.992 (0.951–1.036) | 0.724 | 1.022 (0.996–1.048) | 0.099 | 1.525 (0.584–3.983) | 0.389 |
Pregestational BMI | 1.039 (1.025–1.054) | < 0.001 | 1.040 (1.016–1.065) | 0.001 | 0.999 (0.983–1.015) | 0.923 | ||
Recommended GWG | ||||||||
less | 0.930 (0.636–1.360) | 0.708 | 0.499 (0.244–1.021) | 0.057 | 1.086 (0.771–1.532) | 0.636 | ||
more | 1.255 (0.866–1.820) | 0.230 | 1.928 (1.146–3.244) | 0.013 | 1.215 (0.882–1.673) | 0.233 | ||
Insulin use | 0.653 (0.451–0.946) | 0.024 | 1.670 (0.600–4.643) | 0.326 | 0.757 (0.509–1.126) | 0.170 | ||
Hospitalization | ||||||||
First HbA1c | 1.271 (1.107–1.459) | 0.001 | ||||||
3rd trimester HbA1c | 1.033 (0.874–1.221) | 0.703 | 1.338 (1.117–1.604) | 0.002 | 1.221 (1.083–1.376) | 0.001 | ||
Preeclampsia | 1.354 (1.064–1.723) | 0.014 | ||||||
SGA (WHO chart) | 1.964 (1.199–3.216) | 0.007 | 3.461 (1.207–9.925) | 0.021 | ||||
LGA (WHO chart) | 1.463 (1.124–1.904) | 0.005 | 1.096 (0.459–2.618) | 0.836 | ||||
Prenatal appointments | 0.906 (0810–1.014) | 0.086 |